Pure Global

Investigation of the efficacy of Imeglimin on glycemic control and the underlying mechanisms - Trial UMIN000049203

Access comprehensive clinical trial information for UMIN000049203 through Pure Global AI's free database. This phase not specified trial is sponsored by Toho university and is currently Not yet recruiting. The study focuses on Type 2 diabetes.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000049203
Not yet recruiting
drug
Trial Details
University Hospital Medical Information Network โ€ข UMIN000049203
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Investigation of the efficacy of Imeglimin on glycemic control and the underlying mechanisms
Evaluation of effect on the postprandial glucose elevation and glycemic variability of Imeglimin

Study Focus

Type 2 diabetes

Interventional

drug

Sponsor & Location

Toho university

Japan

Timeline & Enrollment

N/A

Oct 13, 2022

N/A

ICD-10 Classifications

Type 2 diabetes mellitus
Type 2 diabetes mellitus without complications
Type 2 diabetes mellitus with unspecified complications
Type 2 diabetes mellitus with other specified complications
Type 2 diabetes mellitus with multiple complications

Data Source

University Hospital Medical Information Network

UMIN000049203

Non-Device Trial